Nicole Sweeny
Corporate Officer/Principal en KALVISTA PHARMACEUTICALS, INC. .
Perfil
Nicole Sweeny is currently the Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Prior to her current position, she worked as the Vice President of US Marketing at Shire Plc from 2016 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, and Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023.
She received her undergraduate degree from Boston College.
Cargos activos de Nicole Sweeny
Empresas | Cargo | Inicio |
---|---|---|
KALVISTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 25/07/2023 |
Antiguos cargos conocidos de Nicole Sweeny.
Empresas | Cargo | Fin |
---|---|---|
PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 31/03/2023 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/07/2020 |
SHIRE | Corporate Officer/Principal | 01/01/2019 |
Formación de Nicole Sweeny.
Boston College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
KALVISTA PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Nicole Sweeny